Submitted by MNiec on
Executive Interview with Ify Igbunike

Ify Igbunike, Director of Pharmacy Services at University of Maryland Midtown Campus, sat down with Pharmacy Angle to discuss value-based pharmacy practices and narcotic diversion prevention. She shares valuable insights on implementing evidence-based care, the role of behavioral assessments in managing controlled substances, and the complexities of regulatory compliance. Watch the full interview to gain expert knowledge on navigating today's healthcare challenges.

Latest Videos
View all Videos
Executive Insights
Jan 15, 2025

Anthony Curraro, the Director of Pharmacy Operations at Mount Sinai in New York City, shares his insights on the challenges and goals of the organization. He emphasizes the importance of addressing drug shortages and the need for effective plans and protocols to ensure drug availability. With a focus on the biosimilar landscape to reduce costs, Anthony also highlights the significance of mentorship and leadership development within the health system. As he manages direct contracting across multiple care sites, he is committed to improving compound production through automation projects.

Executive Insights
Jan 15, 2025

Charlotte Dixon, the Chief Strategy Pharmacy Contracting Officer at Ochsner Health System, leads a centralized purchasing team in New Orleans with plans to expand into North Louisiana. Her focus is on modeling cost savings and building initiatives while addressing critical drug shortages, particularly in chemotherapy and IV fluids. Charlotte emphasizes the importance of mentorship, transparency, and strategic partnerships to foster growth among pharmacy leaders.

Executive Insights
Dec 02, 2024

Michele Shaeffer, Associate Director of Pharmacy Operations at Jefferson Abington Hospital, shares insights on optimizing pharmacy workflows amidst staffing and medication shortages, highlighting automation and ADC cabinets for improved efficiency and safety. She also emphasizes cross-department collaboration and staff training as essential for addressing these challenges. Looking ahead, she sees innovations in legislation, technology, and industry-wide collaboration as key drivers of progress in tackling systemic issues like drug shortages.